Rockwell Medical, Inc. is a healthcare company. The Company develops, manufactures, commercializes, and distributes a portfolio of hemodialysis products for dialysis providers worldwide. The Company operates in the hemodialysis market, which involves the manufacture, sale and distribution of hemodialysis products to hemodialysis clinics, including pharmaceuticals, dialysis concentrates, dialysis kits and other ancillary products used in the dialysis process. Its hemodialysis concentrates products are used to sustain a patient's life by removing toxins and balancing electrolytes in a dialysis patientโs bloodstream. The Company is the supplier of liquid and dry, acid and bicarbonate concentrates for dialysis patients in the United States. The Company manufactures hemodialysis concentrates at its facilities in Michigan, South Carolina, and Texas, and the Company manufactures its dry acid concentrate mixers at its facility in Iowa.
์ข
๋ชฉ ์ฝ๋ RMTI
ํ์ฌ ์ด๋ฆRockwell Medical Inc
์์ฅ์ผJan 27, 1998
CEOStrobeck (Mark)
์ง์ ์244
์ ํOrdinary Share
ํ๊ณ ์ฐ๋ ์ข
๋ฃJan 27
์ฃผ์30142 Wixom Road
๋์WIXOM
์ฆ๊ถ ๊ฑฐ๋์NASDAQ OMX - NASDAQ BASIC
๊ตญ๊ฐUnited States of America
์ฐํธ ๋ฒํธ48393
์ ํ18004493353
์น์ฌ์ดํธhttps://www.rockwellmed.com/
์ข
๋ชฉ ์ฝ๋ RMTI
์์ฅ์ผJan 27, 1998
CEOStrobeck (Mark)
์ง๋ 5๋
๋์ ์ด
0.00
USD์ ๋ฐฐ๋น๊ธ์ด ๋ถ๋ฐฐ๋์์ต๋๋ค.

๋ฐ์ดํฐ ์์